23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ME | APUS | MBRX | ||
| Company | 23Andme Holding Co. | Apimeds Pharmaceuticals US Inc | Moleculin Biotech CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 0.7480 | 1.5500 | 3.01 | ||
| High | 1.1000 | 1.5500 | 3.16 | ||
| Low | 0.6000 | 0.8900 | 2.94 | ||
| Latest | 0.6063 | 0.9450 | 3.12 | ||
| Change | -0.1637 | -0.1450 | +0.24 | ||
| % Change | -21.26% | -13.30% | +8.33% | ||
| Volume | 29,751,400 | 216,815 | 433,641 | ||
| 20-Day Average Volume | 11,485,064 | 46,701 | 271,547 | ||
| Previous Close | 0.7700 | 1.0900 | 2.88 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4246 | 1.3123 | 2.63 | ||
| 20-Day Raw Stochastic | 4.95% | 7.75% | 95.24% | ||
| 20-Day Relative Strength | 27.35 | 39.61 | 65.83 | ||
| Weighted Alpha | -83.66 | -63.34 | -29.45 | ||
| Today's Opinion | 100% Sell | 100% Sell | 24% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 80% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -66.13% since 03/21/25 | -26.17% since 06/12/26 | +18.18% since 06/12/26 | ||
| Low | 0.5300 on 03/26/25 | 0.8900 on 06/22/26 | 2.65 on 06/15/26 | ||
| High | 1.3700 on 03/27/25 | 1.5500 on 06/22/26 | 3.16 on 06/22/26 | ||
| 1-Month | |||||
| %Chg | -72.44% since 02/28/25 | -37.00% since 05/22/26 | +30.54% since 05/22/26 | ||
| Low | 0.5300 on 03/26/25 | 0.8900 on 06/22/26 | 2.34 on 06/08/26 | ||
| High | 2.0700 on 03/17/25 | 1.6000 on 05/27/26 | 3.16 on 06/22/26 | ||
| 3-Month | |||||
| %Chg | -81.63% since 12/27/24 | -54.13% since 03/20/26 | +51.46% since 03/20/26 | ||
| Low | 0.5300 on 03/26/25 | 0.8900 on 06/22/26 | 2.00 on 05/13/26 | ||
| High | 4.1800 on 01/08/25 | 5.9700 on 05/05/26 | 3.16 on 06/22/26 | ||
| 6-Month | |||||
| %Chg | -89.69% since 09/27/24 | -43.75% since 12/22/25 | -22.19% since 12/22/25 | ||
| Low | 0.5300 on 03/26/25 | 0.8900 on 06/22/26 | 1.79 on 03/09/26 | ||
| High | 7.8800 on 10/02/24 | 5.9700 on 05/05/26 | 5.30 on 02/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,265 | 16,449 | 15,369 | ||
| Shares Outstanding, K | 26,827 | 15,091 | 5,336 | ||
| Annual Sales | 219,640,000 | 0 | 0 | ||
| Annual Net Income | -666,700,000 | -6,000,000 | -33,560,000 | ||
| Last Quarter Sales | 60,260,000 | 0 | 0 | ||
| Last Quarter Net Income | -53,040,000 | -35,060,000 | -12,850,000 | ||
| 60-Month Beta | 1.19 | N/A | 1.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.02 on 01/28/25 | -2.26 on 05/26/26 | -2.48 on 05/14/26 | ||
| Earnings Date | 05/22/25 | 08/18/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||